Cite
HARVARD Citation
Khan, F. et al. (2014). Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO‐incompatible haematopoietic stem cell transplantation. Transfusion medicine. 24 (3), pp. 187-188. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Khan, F. et al. (2014). Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO‐incompatible haematopoietic stem cell transplantation. Transfusion medicine. 24 (3), pp. 187-188. [Online].